Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.0118 | 0.3614 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0118 | 0.3614 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase Chk2 | 0.0118 | 0.3614 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.0774 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.0774 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0041 | 0.0155 | 0.2001 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Trichomonas vaginalis | esterase, putative | 0.0041 | 0.0155 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0041 | 0.0155 | 0.0428 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0041 | 0.0155 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0041 | 0.0155 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0041 | 0.0155 | 0.5 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase I | 0.0118 | 0.3612 | 0.9994 |
Onchocerca volvulus | 0.0041 | 0.0155 | 0.5 | |
Mycobacterium leprae | Probable lipase LipE | 0.0041 | 0.0155 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0041 | 0.0155 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0774 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0041 | 0.0155 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0041 | 0.0155 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0118 | 0.3614 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0041 | 0.0155 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.0155 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0041 | 0.0155 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0041 | 0.0155 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0041 | 0.0155 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0041 | 0.0155 | 0.2001 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Brugia malayi | beta-lactamase family protein | 0.0041 | 0.0155 | 0.2001 |
Mycobacterium ulcerans | lipase LipD | 0.0041 | 0.0155 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0041 | 0.0155 | 0.5 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase I | 0.0118 | 0.3612 | 0.9994 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0041 | 0.0155 | 0.0428 |
Onchocerca volvulus | 0.0041 | 0.0155 | 0.5 | |
Leishmania major | hypothetical protein, conserved | 0.0041 | 0.0155 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0041 | 0.0155 | 0.5 |
Onchocerca volvulus | 0.0041 | 0.0155 | 0.5 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.0774 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Entamoeba histolytica | protein kinase, putative | 0.0118 | 0.3614 | 0.5 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0041 | 0.0155 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.0155 | 0.5 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0041 | 0.0155 | 0.2001 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0155 | 0.2001 |
Brugia malayi | beta-lactamase | 0.0041 | 0.0155 | 0.2001 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0041 | 0.0155 | 0.2001 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
T1/2 (ADMET) | = 0.4 hr | Stability of the compound assessed as half life of porcine pancreatic trypsin-mediated compound degradation at 0.1 mM by reverse-phase HPLC/MS analysis | ChEMBL. | 24044354 |
T1/2 (ADMET) | = 0.4 hr | Stability of the compound assessed as half life of Lysobacter enzymogenes alpha-LP-mediated compound degradation at 0.1 mM by reverse-phase HPLC/MS analysis | ChEMBL. | 24044354 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.